New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 27, 2014
16:27 EDTDG, FINL, MTW, DD, AMED, MNKD, NKEOn The Fly: Closing Wrap
Stocks on Wall Street were higher after a late day rise allowed all of the major averages to end the week on a high note. The averages began the session in negative territory but soon turned mixed. The Nasdaq was able to hold its head above water for most of the session while the Dow struggled for most of the day under the weight of DuPont (DD) shares, which were down more than 3% after the company lowered its guidance. ECONOMIC EVENTS: In the U.S., the final University of Michigan consumer sentiment index for June rose to 82.5, which beat the consensus expectation for a reading of 81.9. COMPANY NEWS: Shares of athletic apparel and footwear giant Nike (NKE) and sports shoe retailer Finish Line (FINL) climbed after both companies reported better than expected quarterly sales and profits. Dow member Nike rose 82c, or 1.07%, to $77.68, while Finish Line advanced 41c, or 1.41%, to $29.56... Another member of the Dow Jones Industrial Average, DuPont, moved in the opposite direction, falling $2.26, or 3.34%, to $65.44 after the industrial conglomerate cut its earnings outlook for its second quarter and its current fiscal year. MAJOR MOVERS: Among the notable gainers was Amedisys (AMED), which rose $4.01, or 29.81%, to $17.46 and was upgraded at CRT Capital after the company gave Q2 guidance. Also higher was Manitowoc (MTW), which gained $3.22, or 10.84%, to $32.93 and was upgraded to Hold at Jefferies after activist Relational Investors took an 8.5% stake in the company and urged for a spin-off of its food business. Among the noteworthy losers was discount retailer Dollar General (DG), which fell $4.49, or 7.28%, to $57.19 after Chief Executive Officer Rick Dreiling announced plans to retire. Also lower were shares of MannKind (MNKD), which dropped 58c, or 5.48%, to $10.00 after the FDA approved its Afrezza inhalation powder to treat diabetes but required the drug to have a Boxed Warning and required the company to conduct several post-marketing studies on the drug. INDEXES: The Dow was up 5.71, or 0.03%, to 16,851.84, the Nasdaq was up 18.88, or 0.43%, to 4,397.93, and the S&P 500 was up 3.74, or 0.19%, to 1,960.96.
News For NKE;DD;FINL;MNKD;MTW;DG;AMED From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 22, 2015
07:04 EDTDDPeltz tried to recruit Gallogly for DuPont board nomination, NY Post says
Subscribe for More Information
06:17 EDTDDAgrium downgraded to Sell from Neutral at Citigroup
Subscribe for More Information
05:58 EDTMNKDStocks with implied volatility above IV index mean; MNKD GMCR
Subscribe for More Information
April 21, 2015
16:26 EDTDDOn The Fly: Top stock stories for Tuesday
Subscribe for More Information
12:33 EDTDDOn The Fly: Top stock stories at midday
Subscribe for More Information
10:00 EDTDDDuPont sees potential for accelerated share repurchases for Chemours dividend
DuPont said it is determining what tool and mechanism to use to complete its share buyback related to Chemours, potentially using an ASR, noting there's also the potential for open market purchases. DuPont repeated that it expects to return to shareholders substantially all of the approximately $4B of one-time dividend proceeds from the spin-off of Chemours within 12-18 months of the separation.
09:26 EDTDDDuPont sees Q2 Performance Chemicals sales, operating earnings to be flat
Subscribe for More Information
09:25 EDTDDDuPont sees Q2 Industrial Biosciences sales about flat
In Industrial Biosciences, DuPont anticipates higher volumes will be offset by the negative impact of currency and softer U.S. biomaterials sales, resulting in Q2 sales that are about flat and operating earnings even with the prior year. In Nutrition and Health, sales are xpected to be high-single digits percent lower in Q2 as volume growth is more than offset by strong currency headwinds. Operating earnings in Nutrition and Health are expected to be low-teens percent lower primarily due to the negative impact of currency. In Agriculture, Q2 sales are seen mid-single-digits percent lower and operating earnings are expected to be down low-to-mid-single digits percent.
09:22 EDTDDDuPont sees Q2 Safety & Protection sales down mid-single digits percent
Subscribe for More Information
09:21 EDTDDDuPont sees Q2 Electronics & Communications sales down about low-teens percent
Subscribe for More Information
09:20 EDTDDDuPont sees Q2 Performance Materials sales down about 'low-teens' percent
Subscribe for More Information
06:09 EDTDDDuPont reports sees Chemours spinoff on track for middle of FY15
Subscribe for More Information
06:06 EDTDDDuPont sees FY15 EPS at low end of $4.00-$4.20, consensus $4.05
Subscribe for More Information
06:04 EDTDDDuPont reports Q1 EPS $1.34, consensus $1.31
Reports Q1 revenue $9.17B, consensus $9.41B.
06:03 EDTMNKDStocks with implied volatility above IV index mean; MNKD GMCR
Stocks with implied volatility above IV index mean; MannKind (MNKD) 75, Keurig Green Mountain (GMCR) 52 according to iVolatility.
06:02 EDTDDDuPont raises Q2 dividend to 49c per share from 47c per share
DuPont declared a Q2 common stock dividend of 49c per share payable June 12, to stockholders of record May 15. This represents a 4% increase over the 47c paid last quarter. The dividend is payable July 24, to stockholders of record July 10.
April 20, 2015
15:37 EDTDDNotable companies reporting before tomorrow's open
Subscribe for More Information
15:03 EDTDDDuPont technical comments before earnings
Subscribe for More Information
12:18 EDTMTWManitowoc elects Carl Icahn representative to board of directors
Subscribe for More Information
06:06 EDTMNKDStocks with implied volatility above IV index mean; MNKD GMCR
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use